Compare companies
| Caplin Point Laboratories Limited | Cipla Limited | Biocon Limited | ||||
|---|---|---|---|---|---|---|
| Capitalization | ||||||
| Price | 1839.5 | 1461.6 | 322.9 | |||
| Price priv. | ||||||
| Number of shares, million | 75.9 | 807.37 | 1196.8 | |||
| Capitalization, billion | 59.72 | 846.5 | 299.31 | |||
| EBITDA, billion | 4.97 | 53.2 | 24.29 | |||
| EV, billion | 52.52 | 820.34 | 446.74 | |||
| Profit and loss report | ||||||
| Net profit, billion | 3.76 | 41.22 | 10.23 | |||
| Revenue, billion | 14.67 | 254.47 | 141.96 | |||
| EPS | 49.57 | 51.05 | 8.54 | |||
| Balance | ||||||
| Assets, billion | 21.91 | 327.18 | 560.71 | |||
| Debt, billion | 0 | 3.85 | 157.3 | |||
| Balance cost, billion | 18.8 | 267.06 | 197.84 | |||
| Cash, billion | 1.78 | 6.4 | 12.33 | |||
| Coefficients | ||||||
| Dividend yield, % | 0 | 0.5498 | 0.4195 | |||
| Dividend | 0 | 13 | 0.5 | |||
| Dividend yield priv., % | 0 | 0 | 0 | |||
| Dividend priv. | 0 | 0 | 0 | |||
| Dividends/profit, % | 8.06 | 16.65 | 19.85 | |||
| P/S | 3.06 | 4.7 | 2.13 | |||
| P/BV | 2.35 | 4.46 | 1.19 | |||
| P/E | 11.92 | 29.01 | 29.51 | |||
| Ev/Ebitda | 10.57 | 17.88 | 16.97 | |||
| Debt/Ebitda | 0 | 0.0724 | 6.48 | |||
| Efficiency | ||||||
| ROE | 20.01 | 16.45 | 5.43 | |||
| ROA | 17.17 | 13.26 | 1.89 | |||
| ROIC | 0 | 14.66 | 1.86 | |||
| Ebitda margin | 33.89 | 20.91 | 17.11 | |||
| Net margin | 25.65 | 16.2 | 7.2 | |||
| Momentum | ||||||
| 1 week, price changes | -5.3 % | +0.2022 % | -3.16 % | |||
| 1 month, price changes | -10.86 % | +0.8139 % | -9.4 % | |||
| 3 months, price changes | -24.79 % | +0.9846 % | -8.45 % | |||
| 6 months, price changes | -6.15 % | -11.93 % | -17.36 % | |||
| 1 year, price changes | +43.98 % | -2.37 % | +20.96 % | |||
| 3 years, price changes | +151.42 % | +48.12 % | -3.03 % | |||
| 5 years, price changes | +541.28 % | +227.05 % | +9.64 % | |||
| 10 years, price changes | ||||||
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
